Cost-Effectiveness of Antibiotics for Geriatric Pneumonia in an Indonesian Regional Hospital

Cyntia Wulandari; Oktaviana Zunnita; Lusi Agus Setiani; Reza Apriandi

doi:10.37311/jsscr.v7i3.34531

Cost-Effectiveness of Antibiotics for Geriatric Pneumonia in an Indonesian Regional Hospital

Cyntia Wulandari, Oktaviana Zunnita, Lusi Agus Setiani, Reza Apriandi

Abstract

Cost-effectiveness of commonly used antibiotic regimens in geriatric inpatients with pneumonia was evaluated through a retrospective review of medical records at Pelabuhan Ratu Regional General Hospital (January–December 2021). Eligible patients were aged ≥60 years with a length of stay ≥2 days; 100 of 700 records met inclusion. Direct medical costs—antibiotics, inpatient care, and other medications—were obtained from hospital tariffs and expressed in Indonesian Rupiah (Rp). Clinical effectiveness at discharge was defined as temperature ≤37,8 °C, respiratory rate <30/min, and leukocyte count ≤10.500/µL. The most frequently used single agents were ceftriaxone (32%), levofloxacin (26%), azithromycin (14%), and cefixime (2%); common substitutions included ceftriaxone–azithromycin (9%) and levofloxacin–ceftriaxone (6%). The lowest average cost-effectiveness ratio (ACER) occurred with cefixime (Rp 581.209). In incremental analysis, levofloxacin–cefixime compared with ceftriaxone monotherapy yielded an incremental cost-effectiveness ratio (ICER) of Rp 117.786 per 1% additional effectiveness, supporting ceftriaxone as the more cost-effective option. Overall, cefixime was most economical by ACER, whereas ceftriaxone monotherapy was preferred by ICER.

Keywords

Antibiotics; Cost-effectiveness; Geriatrics; Pharmacoeconomics; Pneumonia

Full Text:

PDF

References

Ministry of Health of the Republic of Indonesia, "Decision of the Minister of Health of the Republic of Indonesia Number HK.01.07/MENKES/2147/2023 concerning National Guidelines for Medical Services for the Management of Pneumonia in Adults," Decision of the Minister of Health, Jakarta, Indonesia, 21 November 2023. [Online]. Available: https://kemkes.go.id/id/pnpk-2023---tata-laksana-pneumonia-pada-dewasa

Ministry of Health of the Republic of Indonesia, National Report on the 2018 Riskesdas, Jakarta: Ministry of Health of the Republic of Indonesia, 2018. [Online]. Available: https://repository.badankebijakan.kemkes.go.id/id/eprint/3514/1/Laporan%20Riskesdas%202018%20Nasional.pdf

D. Ramadani Putri Papeo et al., “Overview of Pneumonia Treatment in Hospitalised Geriatric Patients at One of the Gorontalo Provincial Hospitals: Case Report ARTICLE INFO,” vol. 2025, no. 2, pp. 126–136, 2021, [Online]. Available: http://dx.doi.org/10.52365/jecp.v5i2.1445

National Institute for Health and Care Excellence (NICE), "Pneumonia: diagnosis and management (NG250)," NICE Guideline, 2 September 2025. [Online]. Available: https://www.nice.org.uk/guidance/ng250.

O. S. Purwanti, R. Abdulah, I. S. Pradipta, and C. Rahayu, "Analysis of Minimising the Cost of Empirical Antibiotic Use in Patients with Respiratory Infection Sepsis," Indonesian Journal of Clinical Pharmacy, vol. 3, no. 1, pp. 10–17, Mar. 2014. [Online]. Available: https://doi.org/10.15416/ijcp.2014.3.1.10

R. Dewi, M. Andriani, and S. P. Oktaviazmi, “Analysis of the Cost Effectiveness of Ceftriaxone and Gentamicin Antibiotics in Paediatric Inpatients with Pneumonia at Hospital X in Jambi in 2018,” Pharma Xplore Scientific Journal of Pharmacy, vol. 6, no. 1, pp. 43–50, May 2021, [Online]. Available: https://doi.org/10.36805/FARMASI.V6I1.1448

R. Rahardjoputro et al., “Cost-Consequence Analysis of Levofloxacin Compared to Ceftriaxone in Community-Acquired Pneumonia of Adult Inpatients at X Hospital Surakarta,” Indonesian Journal of Pharmacy and Pharmaceutical Sciences, vol. 11, no. 1, pp. 89–100, Apr. 2024, [Online]. Available: https://doi.org/10.20473/JFIKI.V11I12024.89-100

Y. Farida, Q. A. Khoiry, M. Hanafi, and M. Maryani, “Cost-effectiveness analysis of empirical antibiotics in hospitalised community-acquired pneumonia,” Pharmaciana, vol. 12, no. 1, p. 83, Mar. 2022, [Online]. Available: https://doi.org/10.12928/pharmaciana.v12i1.21376

T. Nandini, E. Pasam, S. Radha, N. Vinod, and A. Sowmy, “A tertiary care centre’s cost-effective examination of different antibiotic regimens used to treat pneumonia,” Future Journal of Pharmaceuticals and Health Sciences, vol. 5, no. 1, pp. 99–104, February 2025, [Online]. Available: https://doi.org/10.26452/fjphs.v5i1.715

Iqbal Abdul Wahid, Dedy Frianto, and Surya Amal, “Analysis of the Cost Effectiveness of Antibiotic Therapy in Pneumonia Patients at Dewi Sri Hospital Karawang for the Period 2020–2021,” Buana Ilmu, vol. 7, no. 1, pp. 258–268, Dec. 2022, [Online]. Available: https://doi.org/10.36805/BI.V7I1.3198

M., Santoso, et al. "Pola Gangguan Fungsi Organ Pada Pasien Geriatri Di RSUD Koja Jakarta, Periode Juli 2001 – Juni 2005." Maranatha Journal of Medicine and Health, vol. 7, no. 1, 2007. Online]. Available: https://media.neliti.com/media/publications/149169-ID-pola-gangguan-fungsi-organ-pada-pasien-g.pdf

R. Mulyana, “Antibiotic Therapy for Pneumonia in the Elderly,” Jurnal Kesehatan Andalas, vol. 8, no. 1, pp. 172–177, Mar. 2019, [Online]. Available: https://doi.org/10.25077/JKA.V8I1.987

D. Windydaca et al., “Intravenous to Oral Antibiotic Conversion with Length of Community Pneumonia Patients in Klungkung Regional General Hospital,” Pharmaceutical Journal of Indonesia, vol. 18, no. 02, pp. 248–256, 2021. [Online]. Available: https://doi.org/10.30595/pharmacy.v18i2.9216

G. Caragea, O. Avram, A. Pauna, A. C. Costea, and M. Tudosie, “Acetaminophen, a Therapeutic or an Extremely Toxic Remedy—A Review,” Journal of Mind and Medical Sciences 2022, Vol. 9, Pages 102-110, vol. 9, no. 1, pp. 102–110, Apr. 2022, [Online]. Available: https://doi.org/10.22543/7674.91.P102110

A. S. Chidiac, N. A. Buckley, F. Noghrehchi, and R. Cairns, “Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease,” Expert Opinion on Drug and Drug Metabolism Toxicology, vol. 19, no. 5, pp. 297–317, 2023, [Online]. Available: https://doi.org/10.1080/17425255.2023.2223959

S. Choudhari, D. Pawar, A. Bhure, and A. Ade, "CefixView: understanding trends in respiratory infections," Int. J. Basic Clin. Pharmacol, vol. 13, no. 5, pp. 685-690, September 2024. https://doi.org/10.18203/2319-2003.ijbcp20242429 .[Online]. Available: https://www.ijbcp.com/index.php/ijbcp/article/view/5677/3749

N. A. Syaffa, F. Lestari, and B. T. Laksono, "Antibiotic Use Patterns in Pneumonia Patients at Hospital P," Bandung Conference Series: Pharmacy, vol. 5, no. 2, pp. 323–332, 2025, [Online]. Available: https://doi.org/10.29313/bcsp.v5i2.19430 https://proceedings.unisba.ac.id/index.php/BCSP/article/view/19430/8123

M. Elsan Toji, L. Anisyah, A. Riani Hasana, P. Pharmacy Studies, and S. Panti Waluya Health Sciences, “Treatment Profile of Pneumonia in Inpatients at Hospita "X" in Malang City from January to December 2021,” 2023. [Online]. Available: https://doi.org/10.55681/sentri.v2i10.1700 https://repository.stikespantiwaluya.ac.id/id/eprint/304

N. T. Wulandari, E. Listyanti, N. Dyahariesti, and A. R. Erwiyani, "Analysis of the Cost Effectiveness of Treatment in Paediatric Pneumonia Patients in the Inpatient Ward of Dr. Ario Wirawan Salatiga Lung Hospital in 2018," Indonesian Journal of Pharmacy and Natural Product, vol. 2, no. 2, pp. 94–100, September 2019. [Online]. Available: https://doi.org/10.35473/ijpnp.v2i2.276

E. Yudha Prasetyo et al., "Levofloxacin vs Ceftriaxone in Inpatients with Pneumonia at Dr. Iskak Tulungagung Regional Hospital: A Cost-Effectiveness Analysis Study", Desember 2024. https://doi.org/10.47794/medclip [Online]. Available: https://medclip.itsk-soepraoen.ac.id/index.php/medclip/article/view/6

R. Rasmaladewi, M. Sanuddin, and M. Shaleha, “Analysis of the Cost Effectiveness of Ceftriaxone and Ampicillin Antibiotics in Paediatric Inpatients with Pneumonia at Raden Mattaher Regional General Hospital, Jambi, in 2018,” Journal of Healthcare Technology and Medicine, vol. 6, no. 2, p. 616, December 2020, [Online]. Available: https://doi.org/10.33143/JHTM.V6I2.969

Ministry of Health of the Republic of Indonesia, Handbook for the Socialisation of National Health Insurance (JKN). [Online]. Available: http://www.depkes.go.id/resources/download/jkn/buku-pegangan-sosialisasi-jkn.pdf.

U. Salamah, "Cost-effectiveness analysis of antibiotic use in paediatric pneumonia patients in the inpatient ward of Dr. Moewardi General Hospital, Surakarta, in 2016," Thesis, Muhammadiyah University of Surakarta, 2017. [Online]. Available: https://eprints.ums.ac.id/58450/

DOI: https://doi.org/10.37311/jsscr.v7i3.34531

Refbacks

There are currently no refbacks.

EDITORIAL OFFICE OF JOURNAL SYIFA SCIENCES AND CLINICAL RESEARCH

Department of Pharmacy, Gorontalo State University

Jl. Jenderal Sudirman No.6, Kota Gorontalo, Provinsi Gorontalo 96128, Indonesia

Email: [email protected]
Google Scholar : JOURNAL SYIFA SCIENCES AND CLINICAL RESEARCH

Journal Syifa Sciences and Clinical Research (JSSCR) is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Username
Password
Remember me